CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant
October 07, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
October 03, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Oct. 03, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
India Cord Blood Banking Market, Competition, Forecast and Opportunities, 2020-2023 & 2024-2030
August 26, 2024 10:33 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "India Cord Blood Banking Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers
July 17, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Blood Bank Global Market Report 2024: Strategic Partnerships and Acquisitions Among Industry Leaders Prompting Business Expansion - Long-term Forecasts to 2028 and 2033
January 29, 2024 11:27 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Blood Bank Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Blood Bank Market Sees Robust Expansion...
Global Blood Market 2024-2028 - Growing Demand for Blood Products and Rising Demand for Cord Blood Banking to Lead to Sizable Market Demand
January 09, 2024 10:53 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Blood Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The blood market is forecasted to grow by USD 2.60 billion...
U.S. Cord Blood Banking Services Market Trends Analysis Report 2023-2030: Rising Applications Of Cord Blood For Treatment Of Various Disease Conditions Bolsters Growth
July 06, 2023 10:03 ET
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "U.S. Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States...
Global Cord Blood Banking Global Market Report 2022: Featuring Americord Registry, Cordlife Group, Lifecell International & More
October 17, 2022 08:33 ET
|
Research and Markets
Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Market by Service, Component, Application, Sector, Company, and Region: Competition Forecast and Opportunities to 2027"...
Outlook on the Cord Blood Banking Services Global Market to 2027 - by Component, Storage Services, Application and Region
October 10, 2022 04:53 ET
|
Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Cord Blood Banking Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Stem Cell/Cord Blood Banking Market Outlook Report 2022: CAGR of 9% with Market Set to Reach $14.44 Billion in 2026
April 19, 2022 04:18 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell/Cord Blood Banking Global Market Report 2022, By Cell Type, By Service, By Bank Type, By Application" report has been added to...